These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 34582559)
1. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559 [TBL] [Abstract][Full Text] [Related]
2. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824 [TBL] [Abstract][Full Text] [Related]
3. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185 [TBL] [Abstract][Full Text] [Related]
4. Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin. Svoboda LK; Bailey N; Van Noord RA; Krook MA; Harris A; Cramer C; Jasman B; Patel RM; Thomas D; Borkin D; Cierpicki T; Grembecka J; Lawlor ER Oncotarget; 2017 Jan; 8(1):458-471. PubMed ID: 27888797 [TBL] [Abstract][Full Text] [Related]
5. Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Fiskus W; Boettcher S; Daver N; Mill CP; Sasaki K; Birdwell CE; Davis JA; Takahashi K; Kadia TM; DiNardo CD; Jin Q; Qi Y; Su X; McGeehan GM; Khoury JD; Ebert BL; Bhalla KN Blood Cancer J; 2022 Jan; 12(1):5. PubMed ID: 35017466 [TBL] [Abstract][Full Text] [Related]
6. NUP98-MLL fusion in human acute myeloblastic leukemia. Kaltenbach S; Soler G; Barin C; Gervais C; Bernard OA; Penard-Lacronique V; Romana SP Blood; 2010 Sep; 116(13):2332-5. PubMed ID: 20558618 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation. Chen Y; Ernst P Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857 [TBL] [Abstract][Full Text] [Related]
8. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression. Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649 [TBL] [Abstract][Full Text] [Related]
11. Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia. Brzezinka K; Nevedomskaya E; Lesche R; Steckel M; Eheim AL; Haegebarth A; Stresemann C J Hematol Oncol; 2019 Jun; 12(1):66. PubMed ID: 31253180 [TBL] [Abstract][Full Text] [Related]
12. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. Klossowski S; Miao H; Kempinska K; Wu T; Purohit T; Kim E; Linhares BM; Chen D; Jih G; Perkey E; Huang H; He M; Wen B; Wang Y; Yu K; Lee SC; Danet-Desnoyers G; Trotman W; Kandarpa M; Cotton A; Abdel-Wahab O; Lei H; Dou Y; Guzman M; Peterson L; Gruber T; Choi S; Sun D; Ren P; Li LS; Liu Y; Burrows F; Maillard I; Cierpicki T; Grembecka J J Clin Invest; 2020 Feb; 130(2):981-997. PubMed ID: 31855575 [TBL] [Abstract][Full Text] [Related]
13. Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. Dzama MM; Steiner M; Rausch J; Sasca D; Schönfeld J; Kunz K; Taubert MC; McGeehan GM; Chen CW; Mupo A; Hähnel P; Theobald M; Kindler T; Koche RP; Vassiliou GS; Armstrong SA; Kühn MWM Blood; 2020 Nov; 136(21):2442-2456. PubMed ID: 32589720 [TBL] [Abstract][Full Text] [Related]
14. The MLL-Menin Interaction is a Therapeutic Vulnerability in Rasouli M; Blair H; Troester S; Szoltysek K; Cameron R; Ashtiani M; Krippner-Heidenreich A; Grebien F; McGeehan G; Zwaan CM; Heidenreich O Hemasphere; 2023 Aug; 7(8):e935. PubMed ID: 37520776 [TBL] [Abstract][Full Text] [Related]
15. Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations. Miao H; Chen D; Ropa J; Purohit T; Kim E; Sulis ML; Ferrando A; Cierpicki T; Grembecka J Leukemia; 2024 Aug; 38(8):1674-1687. PubMed ID: 38890447 [TBL] [Abstract][Full Text] [Related]
16. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235 [TBL] [Abstract][Full Text] [Related]
17. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. Krivtsov AV; Evans K; Gadrey JY; Eschle BK; Hatton C; Uckelmann HJ; Ross KN; Perner F; Olsen SN; Pritchard T; McDermott L; Jones CD; Jing D; Braytee A; Chacon D; Earley E; McKeever BM; Claremon D; Gifford AJ; Lee HJ; Teicher BA; Pimanda JE; Beck D; Perry JA; Smith MA; McGeehan GM; Lock RB; Armstrong SA Cancer Cell; 2019 Dec; 36(6):660-673.e11. PubMed ID: 31821784 [TBL] [Abstract][Full Text] [Related]
18. MLL is essential for NUP98-HOXA9-induced leukemia. Shima Y; Yumoto M; Katsumoto T; Kitabayashi I Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005 [TBL] [Abstract][Full Text] [Related]
19. Complexity of Blocking Bivalent Protein-Protein Interactions: Development of a Highly Potent Inhibitor of the Menin-Mixed-Lineage Leukemia Interaction. Borkin D; Klossowski S; Pollock J; Miao H; Linhares BM; Kempinska K; Jin Z; Purohit T; Wen B; He M; Sun D; Cierpicki T; Grembecka J J Med Chem; 2018 Jun; 61(11):4832-4850. PubMed ID: 29738674 [TBL] [Abstract][Full Text] [Related]
20. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]